Twist Bioscience Corporation (NASDAQ: TWST) reported Q2 EPS of ($0.71), $0.23 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $110.72 million versus the consensus estimate of $107.65 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.